| Submission of formal petitions and representations to PMDA [Pharmaceuticals and Medical Devices Agency] and the MHLW [Mōrōshō – Ministry of Health, Labour and Welfare]. | 患者擁護
> 患者擁護 | 規制上のパートナーシップ
> 医療技術評価（HTA）および償還審査への参加 | 100 | National | Sometimes | 119036459439 |
| Towards the approval of molecularly targeted therapies. | がん
> がん：肺 | 規制上のパートナーシップ
> マーケティング承認申請への貢献 | 1,000 | Regional | Rarely | 119053044699 |
| We submit a formal petition to the [Japanese] Ministry of Health, Labour and Welfare (MHLW) once a year and conduct a follow-up meeting. | 移植
> 移植数：最多 | 規制上のパートナーシップ
> 政策立案者・規制当局との会議への出席・ファシリテーション | 100 | National | Regularly | 119051955551 |
| I participate in petition campaigns through the National Psoriasis Patients Federation. | スキン
> 乾癬 | 規制上のパートナーシップ
> 他の医療擁護者と | 100 | Regional | Rarely | 119013683256 |
| Every year, we submit budget requests for the following fiscal year to the national government and prefectural governments. | 肝臓
> 肝疾患：ほとんどの種類 | 政策と法律への影響
> 医療政策と法律に影響を与える | 5,000 | National | Regularly | 119036457777 |
| We have organised vaccine awareness marches and submitted formal written requests to the Kōrōshō [厚生労働省 – Ministry of Health, Labour and Welfare]. | 感染性
> 感染症：その他 | 政策と法律への影響
> 公聴会やパブリックコンサルテーションに参加する | 100 | National | Sometimes | 119035140720 |
| We submit a formal written petition to the MHLW [Mōsō Rōdōshō – Ministry of Health, Labour and Welfare] once a year. | 移植
> 移植数：最多 | 政策と法律への影響
> 公聴会やパブリックコンサルテーションに参加する | 100 | National | Regularly | 119051955551 |
| Once a year, the organisation submits its formal requests at the opinion exchange forum held jointly with the prefectural and municipal authorities. | リウマチ性
> リウマチ性疾患：その他 | 政策と法律への影響
> 公聴会やパブリックコンサルテーションに参加する | 100 | National | Regularly | 119078001121 |
| Visited the House of Representatives members' office building and held a meeting with a member of parliament. | リウマチ性
> リウマチ性疾患：ほとんどの種類 | 政策と法律への影響
> 国会議員や政治指導者を動員する | 1,000 | National | Rarely | 119014930939 |
| Submission of a written petition to the Minister of Health, Labour and Welfare. | 内分泌
> 糖尿病：1型 | 政策と法律への影響
> 国会議員や政治指導者を動員する | 100,000 | National | Regularly | 119019815441 |
| Expedited approval of stem cell-based regenerative medicine products. | レア
> 希少疾患：EB | 政策と法律への影響
> 医療における障壁・異常への対処 | 1,000 | National | Sometimes | 119077906981 |
| Early approval of new medicines, resolution of drug lag and drug loss, and applications based on established medical knowledge. | がん
> がん：膵臓 | 政策と法律への影響
> 医療における障壁・異常への対処 | 10,000 | National | Regularly | 119079604807 |
| Insurance reimbursement coverage for Pegasys [peginterferon alfa-2a, used to treat chronic hepatitis B and C, as well as rare cancers]. | がん
> がん：血液 | 価格設定と手頃な価格の擁護
> 製品の償還リスト/国家医薬品集への収載推進 | 1,000 | National | Regularly | 119014697897 |
| We have organised vaccine awareness marches and submitted formal written requests to the Kōrōshō [厚生労働省 – Ministry of Health, Labour and Welfare]. | 感染性
> 感染症：その他 | 価格設定と手頃な価格の擁護
> 啓発キャンペーンへの参加 | 100 | National | Sometimes | 119035140720 |
| A request for greater disease awareness. | 未指定
> 未指定 | 価格設定と手頃な価格の擁護
> 啓発キャンペーンへの参加 | 100 | National | Regularly | 119061457501 |
| Towards the approval of molecularly targeted therapies [for lung cancer]. | がん
> がん：肺 | アクセス経路の改善
> 医薬品・医療への公平なアクセスを促進する | 1,000 | Regional | Rarely | 119053044699 |
| Key advocacy priorities include: accelerated approval pathways for new medicines, resolution of drug lag and drug loss issues, and the known-use application process (applications for medicines already recognised in the scientific literature or approved in other jurisdictions). | がん
> がん：膵臓 | アクセス経路の改善
> 医薬品・医療への公平なアクセスを促進する | 10,000 | National | Regularly | 119079604807 |
| We have organised vaccine awareness marches and submitted formal written requests to the Kōrōshō [厚生労働省 – Ministry of Health, Labour and Welfare]. | 感染性
> 感染症：その他 | アクセス経路の改善
> より広いワクチンアクセスを推進する | 100 | National | Sometimes | 119035140720 |
| Insurance reimbursement coverage for Pegasys [peginterferon alfa-2a, used to treat chronic hepatitis B and C, as well as rare cancers]. | がん
> がん：血液 | アクセス経路の改善
> 希少・超希少疾患治療へのアクセス改善 | 1,000 | National | Regularly | 119014697897 |
| Expedited approval of stem cell-based regenerative medicine products. | レア
> 希少疾患：EB | アクセス経路の改善
> 希少・超希少疾患治療へのアクセス改善 | 1,000 | National | Sometimes | 119077906981 |
| The Ministry of Health, Labour and Welfare; the Medical Insurance Subcommittee of the Social Security Council; and related bodies. | アレルギー
> アレルギー | 機関ガバナンス
> 政府の諮問機関における代表性を確保する | 100,000 | National | Sometimes | 119078144899 |
インタラクション
アクションと支援活動
4 メンション
